









Markets
/
Stocks
/
nasdaq-gehc
/

GE Healthcare Technologies Inc

GEHC



View Detailed Chart

85.460USD

+2.940+3.56%

Close 12/05, 16:00（ET）Quotes delayed by 15 min

38.93BMarket Cap

17.56P/E TTM



GE Healthcare Technologies Inc

85.460

+2.940+3.56%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

+3.56%

5 Days

+6.84%

1 Month

+15.22%

6 Months

+19.32%

Year to Date

+9.31%

1 Year

+5.19%

View Detailed Chart

TradingKey Stock Score of GE Healthcare Technologies Inc

Currency: USD Updated: 2025-12-05

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

GE Healthcare Technologies Inc's Score

Industry at a Glance

Industry Ranking

24 / 207

Overall Ranking

86 / 4582

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 22 analysts

Buy

Current Rating

87.818

Target Price

+2.76%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

GE Healthcare Technologies Inc Highlights

StrengthsRisks

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Undervalued

The company’s latest PE is 17.61, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 403.23M shares, increasing 1.73% quarter-over-quarter.

Held by Ken Fisher

Star Investor Ken Fisher holds 4.55K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.10.

GE Healthcare Technologies Inc News

Inside Nvidia’s Investment Blueprint: Mapping the Next Empire of AI, Automation, and Infrastructure

TradingKey - Nvidia (NVDA) is no longer just the leader of GPU chips, the company is transforming into something more. As the company heads towards the much-awaited annual shareholder meet, a sharper mental picture comes as to what exactly it’s building: an empire beyond silicon.

TradingKeyWed, Jun 25